Mather Group, Llc. Horizon Therapeutics Public LTD CO Transaction History

Mather Group, Llc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$96.34 - $112.38 $6,647 - $7,754	69 Added 2.5%	2,828 $290,000
Q4 2022 Mar 10, 2023	BUY	$62.39 - $113.8 $172,134 - $313,974	2,759 New	2,759 $313,000
Q2 2022 Aug 16, 2022	SELL	$79.4 - $116.36 $449,324 - $658,481	-5,659 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $80,197 - $101,903	-928 Reduced 14.09%	5,659 $595,000
Q4 2021 Feb 15, 2022	BUY	$98.56 - $119.91 $649,214 - $789,847	6,587 New	6,587 $710,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

Stay updated on Mather Group, Llc. with notifications on news.